IDK. It seems like others here think it is a material issue that would need to be disclosed, but the question is how long can they sit on it. My gut is telling me they will try to paper over the BARDA miss.with some lesser "good news" on the CC
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links